Unity Biotechnology’s investigational eye treatment failed to match Eylea at 20 weeks—part of the mid-stage trial’s primary endpoint and the only time stamp out of 10 in which the candidate ...
House Bill 1393, which aims to give parents of children with IEPs more of a choice in their child’s education, is headed to the Senate for further consideration.
The TALON trial in the wet form of AMD will compare brolucizumab against Eylea (aflibercept) on a range of measures, including visual acuity and treatment interval duration, to see if it can ...
a form of the disease where abnormal blood vessels grow in the back of the eye. They all had severe disease and a high treatment burden with an average of 10 injections with Eylea (aflibercept), a ...
The Eylea franchise was in need of a win after an appellate court last week denied the pharma’s bid to block Amgen’s biosimilar from the U.S. Two investigational eye therapies, from Opthea Limited and ...
Opthea and Unity Biotechnology, which are both developing new drugs for eye diseases, were unable to beat or match aflibercept, the standard-of-care treatment that Regen ...
Klaro Privacy Manager. An open-source, privacy-friendly & compliant consent manager for your website.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback